Goodwin Procter and Dechert advised Relay Therapeutics, Inc. in the offering, and Ropes & Gray advised the underwriters.Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine…
Relay Therapeutics’ $200 Million Follow-on Offering
